Concepedia

Huanyu Shi

HS

Statistics

Publications

3

Citations

45

H-Index

3

Active since

2018

Affiliations

Shanghai Institute of Materia Medica(Current)

University of Chinese Academy of Sciences

Chinese Academy of Sciences

Huanyu Shi is an author at Shanghai Institute of Materia Medica specializing in drug development, medicinal chemistry, and drug discovery.

ORCID

Top concepts

Publications per year

2018–2022

3

Publications

3

Development of a series of quinazoline-2,5-diamine derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors

Huanyu Shi, Haotian Tang, Yan Li et al. · European Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

, , +11

Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma

Qi Wang, Yang Dai, Yinchun Ji et al. · European Journal of Medicinal Chemistry · 2018 · 16 citations · Full text

, , +11

Discovery of 4-cyclopropyl-3-(2-((1-cyclopropyl-1H-pyrazol-4-yl) amino) quinazolin-6-yl)-N-(3-(trifluoromethyl) phenyl) benzamides as potent discoidin domain receptor inhibitors for the treatment of idiopathic pulmonary fibrosis

Qi Wang, Bixi Tang, Dandan Sun et al. · Acta Pharmaceutica Sinica B · 2021 · 10 citations · Full text

1–3 of 3